Abstract
Sentinel lymph node dissection (SLND) for melanoma and breast cancer has been validated as an accurate technique to assess the status of the lymph nodes in the regional drainage basin. The sentinel node concept has also been investigated in other solid tumors, and more recently, in thyroid carcinoma. SLND using a vital blue dye during thyroidectomy for suspected thyroid malignancy successfully identifies sentinel nodes, with minimal morbidity. Excised sentinel nodes can be examined for micrometastases, and if negative, then the rest of the cervical nodes are likely to be negative. The false negative rate of SLND for thyroid malignancy is unknown, however, because modified neck dissections have not accompanied all cases. The impact that lymph node metastasis in thyroid carcinoma has on prognosis is debatable, unlike breast cancer and melanoma, which therefore makes the utility of thyroid SLND less clear. The technique, results, and morbidity of SLND during thyroidectomy is presented, and its possible utility in well-differentiated and medullary thyroid carcinoma is discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Morton DL, Wen DR, Wong JH..., et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Reintgen D, Cruse CW, Wells K, et al (1994) The orderly progression of melanoma nodal metastases. Ann Surg 220:759–767
Thompson JF, McCarthy WH, Bosch CM, et al (1995) Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5:255–260
Giuliano AE, Kirgan DM, Guenther JM..., et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401
Giuliano AE, Jones RC, Brennan M, et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350
Keleman PR, Van Herle AJ, Giuliano AE (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133:288–292
Noguchi S, Muranaki N (1987) The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 67:251–61
Frazell EL, Foote FW (1955) Papillary thyroid carcinoma: Pathologic findings in cases with and without clinical evidence of cervical node involvement. Cancer 8:1164
Scheumann GFW, Gimm O, Wegener G, et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568
Sato N, Oyamatsu M, Koyama Y, et al (1998) Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151–5
Carcangiu ML, Zampi G, Pupi A, et al (1985) Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–28
Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–8
Cunningham MP, Duda RB, Recant W, et al (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344–7
Hamming JF, Roukema JA (1997) Management of regional lymph nodes in papillary, follicular, and medullary thyroid carcinoma. In: Clark OH, Duh QY (eds) Textbook of Endocrine Surgery. Philadelphia, WB Saunders, p 155
Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947–53
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–28
McHenry CR, Rosen IB, Walfish PG (1991) Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162:353–356
Hamming JF, Van de Velde CJH, Fleuren GJ et al (1988) Differentiated thyroid cancer: a stage-adapted approach to the treatment of regional lymph node metastasis. Eur J Cancer Clin Oncol 24:325–330
Henry JF, Gramatica L, Denizot A et al (1998) Morbidity of prophylactic lymph node dissect ion in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383:167–169
Cady B, Sedgewick CE, Meissner WA et al (1979) Risk factor analysis in differentiated thyroid cancer. Cancer 43:810–820
Harwood J, Clark OH, Dunphy JE... (1978) Significance of lymph node metastases in different iated thyroid cancer. Am J Surg 136:107–110
Block MA, Jackson CE, Tshjian AH Jr (1980) Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma: Treatment implications. Arch Surg 115:142–148
Russell CF, van Heerden JA, Sizemore GW... et al (1983) The surgical management of medullary thyroid carcinoma Ann Surg 197:42–48
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Haigh, P.I., Giuliano, A.E. (2000). Sentinel Lymph Node Dissection for Thyroid Malignancy. In: Schlag, P.M., Veronesi, U. (eds) Lymphatic Metastasis and Sentinel Lymphonodectomy. Recent Results in Cancer Research, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57151-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-57151-0_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63070-5
Online ISBN: 978-3-642-57151-0
eBook Packages: Springer Book Archive